ODIIX
Price
$175.06
Change
+$4.11 (+2.40%)
Updated
Jun 2 closing price
Net Assets
7.76B
WCMNX
Price
$14.98
Change
+$0.18 (+1.22%)
Updated
Jun 2 closing price
Net Assets
53.09M
Interact to see
Advertisement

ODIIX vs WCMNX

Header iconODIIX vs WCMNX Comparison
Open Charts ODIIX vs WCMNXBanner chart's image
ODIIX vs WCMNX Comparison Chart in %
View a ticker or compare two or three
VS
ODIIX vs. WCMNX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ODIIX is a Buy and WCMNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ODIIX has more cash in the bank: 7.76B vs. WCMNX (53.1M). ODIIX (0.00) and WCMNX (0.00) have matching dividends . ODIIX was incepted earlier than WCMNX: ODIIX (14 years) vs WCMNX (7 years). WCMNX (2.04) is less costly to investors than ODIIX (0.65). WCMNX (89.00) and ODIIX (87.00) have comparable annual turnover. WCMNX has a lower initial minimum investment than ODIIX: WCMNX (1000) vs ODIIX (1000000). ODIIX annual gain was more profitable for investors over the last year : 40.08 vs. WCMNX (25.42). ODIIX return over 5 years is better than : 23.57 vs. WCMNX (-1.40).
ODIIXWCMNXODIIX / WCMNX
Total Expense Ratio0.651.2452%
Annual Report Gross Expense Ratio0.652.0432%
Fund Existence14 years7 years-
Gain YTD28.0919.225305%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets7.76B53.1M14,618%
Annual Yield % from dividends0.000.00-
Returns for 1 year40.0825.42158%
Returns for 3 years74.1031.21237%
Returns for 5 years23.57-1.40-1,685%
Returns for 10 years127.54N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IILGX32.710.13
+0.40%
Thrivent Global Stock S
BLDRX9.740.01
+0.10%
BlackRock Managed Income K
RYENX313.96N/A
N/A
Rydex Energy A
FPACX45.31N/A
N/A
FPA Crescent
NSCCX43.02N/A
N/A
Nuveen Small-Cap Value Opps C